Replimune (REPL) stock plunged 19% after FDA rejected RP1 melanoma treatment for the second time, citing trial design issues.
Rohirrim, the leading provider of secure, domain-aware generative AI solutions for enterprise and government proposal and acquisition automation, today announced that its UnifiedAcquire(TM) platform ...
A 2-week ceasefire between the U.S. and Iran sparked a broad-based relief rally across risk assets, and even buoying ...
Asia-Pacific markets opened higher after President Donald Trump said he agreed to suspend planned attacks on Iranian ...
Bitcoin falls to $68,589 while oil tops $112 as Trump sets midnight Iran deadline. Stock futures decline ahead of critical ...
Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Doge Jones Industrial Average is a global digital currency exchange offering cryptocurrency trading, advanced tools, and ...
9d
Why Delta, Starbucks and these other stocks were just added to a market-beating 'fresh money' list
Stocks are poised to tumble as oil surges ahead of a long holiday weekend, after a speech from President Donald Trump failed to offer a clear timeline on when the Iran conflict will end. For those ...
Headline sales rose 0.6%, a step up from January's 0.1% decline and better than the projected 0.5% growth. Read more here.
Wall Street ended ​sharply higher on Tuesday, lifted by speculation about a potential de-escalation in the Middle East ...
The San Francisco 49ers may have made their final move along the offensive line before the start of the 2026 NFL draft. With the addition of Robert Jones in the mix, what does the 49ers depth chart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results